Invited review: Completeness of reporting of experiments: REFLECTing on a year of animal trials in the Journal of Dairy Science by Winder, Charlotte B. et al.
Masthead Logo
Veterinary Diagnostic and Production Animal
Medicine Publications
Veterinary Diagnostic and Production Animal
Medicine
2019
Invited review: Completeness of reporting of
experiments: REFLECTing on a year of animal
trials in the Journal of Dairy Science
Charlotte B. Winder
University of Guelph
Katheryn J. Churchill
University of Guelph
Jan M. Sargeant
University of Guelph
Stephen J. LeBlanc
University of Guelph
Annette M. O'Connor
Iowa State University, oconnor@iastate.edu
See next page for additional authors
Follow this and additional works at: https://lib.dr.iastate.edu/vdpam_pubs
Part of the Animal Experimentation and Research Commons, and the Large or Food Animal and
Equine Medicine Commons
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
vdpam_pubs/134. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Veterinary Diagnostic and Production Animal Medicine at Iowa State University Digital
Repository. It has been accepted for inclusion in Veterinary Diagnostic and Production Animal Medicine Publications by an authorized administrator
of Iowa State University Digital Repository. For more information, please contact digirep@iastate.edu.
Invited review: Completeness of reporting of experiments: REFLECTing
on a year of animal trials in the Journal of Dairy Science
Abstract
Reproducibility is an essential element of the scientific process, and it requires clear and complete reporting of
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associated with biased effect estimates. Moreover, incomplete reporting precludes knowledge synthesis and
undervalues the resources allocated to the primary research. The Reporting Guidelines for Randomized
Controlled Trials for Livestock and Food Safety (REFLECT) statement, published in 2010, is a checklist
developed by expert consensus to provide guidance on what study elements should be reported in any
intervention trial (designed experiment) involving livestock. The Journal of Dairy Science ( JDS) has recently
endorsed the use of reporting guidelines. To assess the status of reporting of controlled experiments in JDS
and to provide a baseline for future comparison, we evaluated the reporting of 18 items from the REFLECT
statement checklist in a sample of 137 controlled trials published in JDS in 2017. Two reviewers
independently screened titles and abstracts for relevance and then evaluated a sample of 120 papers reporting
controlled trials (experimental studies involving at least one intervention and one comparison or control
group), using yes or no questions. Although some items, such as treatment details and statistical analysis, were
well reported, other areas, including sample size justification, allocation concealment, blinding, study flow,
baseline data, and ancillary analyses, were often not reported or were incompletely described. This work
highlights the need for authors and reviewers to take advantage of guidelines and checklists for reporting.
Adherence to reporting guidelines can help improve the completeness of reporting of research, expedite and
better inform the peer-review process, increase clarity for the reader, and allow for knowledge synthesis, such
as meta-analysis, all of which serve to increase the value of the work conducted.
Keywords
reporting guidelines, trials, transparency, reproducibility
Disciplines
Animal Experimentation and Research | Large or Food Animal and Equine Medicine
Comments
This is a manuscript of an article published as Winder, Charlotte B., Katheryn J. Churchill, Jan M. Sargeant,
Stephen J. LeBlanc, Annette M. O'Connor, and David L. Renaud. "Invited review: Completeness of reporting
of experiments: REFLECTing on a year of animal trials in the Journal of Dairy Science." Journal of Dairy
Science (2019). DOI: 10.3168/jds.2018-15797. Posted with permission.
Authors
Charlotte B. Winder, Katheryn J. Churchill, Jan M. Sargeant, Stephen J. LeBlanc, Annette M. O'Connor, and
David L. Renaud
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/vdpam_pubs/134
 1 
Completeness of reporting of experiments: REFLECTing on a year of animal trials in the 
Journal of Dairy Science. Winder et al., page xxxx.  Reproducibility in science requires 
comprehensive and accurate reporting of study design, conduct, and analysis. This observational 
study examined the prevalence of reporting of the 18 objective items in the Reporting Guidelines 
for Randomized Control Trials in Livestock and Food Safety (REFLECT) in trials published in 
the Journal in 2017.  We found that while some items were well reported, there is room for 
improvement. Authors and reviewers should employ guidelines and checklists appropriate for 
their study type.  
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ABSTRACT 
 
Reproducibility is an essential element of the scientific process, and requires clear and complete 
reporting of study design, conduct, and analysis. In human and animal health literature, 
incomplete reporting is associated with biased effect estimates.  Moreover, incomplete reporting 
precludes knowledge synthesis and undervalues the resources allocated to the primary research.  
The Reporting Guidelines for Randomized Controlled Trials for Livestock and Food Safety 
(REFLECT) statement, published in 2010, is a checklist developed by expert consensus to 
provide guidance on what study elements should be reported in any intervention trial (designed 
experiment) involving livestock. The Journal of Dairy Science has recently endorsed the use of 
reporting guidelines. To assess the status of reporting of controlled experiments in the Journal 
and to provide a baseline for future comparison, we evaluated the reporting of 18 items from the 
REFLECT statement checklist in a sample of 137 controlled trials published in the Journal in 
2017. Two reviewers independently screened titles and abstracts for relevance, and then 
evaluated a sample of 120 papers reporting controlled trials (experimental studies involving at 
least one intervention and one comparison or control group), using yes or no questions. While 
some items, such as treatment details and statistical analysis, were well-reported, other areas 
including sample size justification, allocation concealment, blinding, study flow, baseline data, 
and ancillary analyses were often not reported or incompletely described. This work highlights 
the need for authors and reviewers to take advantage of guidelines and checklists for reporting. 
Adherence to reporting guidelines can help improve the completeness of reporting of research, 
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expedite and better inform the peer-review process, increase clarity for the reader, and allow for 
knowledge synthesis, such as meta-analysis, all of which serve to increase the value of the work 
conducted.    
Keywords:  
reporting guidelines, 
trials,  
transparency, 
reproducibility 
 
INTRODUCTION 
Concerns about incomplete reporting of research studies have been noted for decades 
(Sandifier et al., 1961) and have been identified in trials in livestock (Burns and O’Connor, 2008; 
Sargeant et al., 2009a; Sargeant et al., 2009b; Haimerl et al., 2012), food safety (Sargeant et al., 
2009b), and veterinary medicine (Lund et al., 1998). Although a study may have been well 
designed and executed, if the details documenting this rigor are not made explicit in the 
publication, readers cannot be certain what was done, and it becomes difficult to reproduce the 
research. Studies which fail to report key design features, such as random allocation, exclusion 
criteria, or details of intervention protocols and outcome measures, are more likely to report a 
positive intervention effect (Wellman and O’Connor, 2007; Burns and O’Connor, 2008; Sargeant 
et al., 2009a; Sargeant et al., 2009b; Brace et al., 2010). Additionally, if details of the conduct of 
a study are not clearly reported, the experiment often cannot be included in later meta-analysis, 
even if the data are relevant and would otherwise contribute. Concerns around incomplete 
reporting prompted the development of evidence-based reporting guidelines, such as the 
 4 
Reporting guidElines For randomized controLled trials for livestock and food safety 
(REFLECT), which was developed by a consensus of experts to improve the quality of reporting 
of trials in livestock species (Sargeant et al., 2010). 
Research synthesis is a fundamental part of science. Replication and consistency of 
results among studies are important to be able to draw conclusions about the effects of 
interventions. Systematic reviews and meta-analyses are becoming a common approach to 
research synthesis in animal science. The purpose of systematic reviews is to synthesize 
information across multiple experiments or studies to yield a high level of evidence for a specific 
research question. Systematic reviews often also include a meta-analysis, which takes into 
account within- and among-study variation when calculating the summary effect of an 
intervention. Systematic reviews also assess the risk of bias based on study design elements to 
aid interpretation of the summary effect. 
Incomplete reporting in primary studies is a common finding in systematic reviews in 
animal health research (Dzikamunkenga et al., 2014; Baltzell et al., 2015), and limits the ability 
to answer relevant questions (Winder et al., 2018; Ali Naqvi et al., 2018).  A lack of detail in 
reporting results in studies with suitable intervention groups and outcomes being excluded from 
meta-analysis (Rodney et al., 2105; Haimerl et al., 2017), thus reducing the utility and impact of 
these individual studies. 
Reporting guidelines function as a minimum standard to ensure that details related to key 
items are included, which provides a framework to assist both authors and reviewers, and 
improves clarity for the reader.  This may help the research reach a wider audience, and, if 
consulted early in the process, can facilitate study design by ensuring key design components are 
considered. It should be stressed that reporting guidelines are not meant to prescribe how 
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researchers should design or execute their study, nor are they intended to be used as an 
assessment of the methodologic quality of the trial; reporting guidelines are an assessment of 
comprehensive reporting.  Experiments may have different types of treatments (e.g. nutrition, 
reproductive protocols, vaccination, etc.), which may influence the reader’s interpretation of the 
importance of adherence to specific design elements.  However, reporting of fundamental 
elements of the design and conduct of an experiment is always necessary in order to allow for  
assessment of the study’s results.  For example, blinding of outcome assessors may be more or 
less important, or practically achievable, depending on the treatment or outcome in question. 
Comprehensive reporting does not mean that authors must always use blinding, but rather, it 
means that authors should always report whether or not blinding was used. 
Thus, reporting guidelines serve to inform the reader or reviewer of the details of how the 
trial was conducted in such a way that the work could then be assessed for bias. Studies may be 
well-reported but poorly conducted; these should be rejected at peer-review. Conversely, peer-
reviewed publication does not necessarily ensure that all important elements are clearly reported 
in a paper. Without appropriate reporting, it is not possible for reviewers and readers to assess 
the potential for bias, and therefore interpretation and applicability of the results are limited. 
Conversely, comprehensive reporting helps to maximize the value of work undertaken, by 
providing end-users with sufficient information to fully understand the assess potential bias, and 
to synthesise results.  Standardized reporting allows for better evaluation of research integrity 
and minimizes potential misinterpretation (White and Larson, 2015). An ethical as well as a 
financial argument can be made for ensuring that best use is made of resources such as research 
animals and public funding.   
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The use of reporting guidelines is now endorsed by the Journal of Dairy Science in their 
Instructions for Authors https://www.journalofdairyscience.org/content/inst-auth , with 
encouragement of submission of a completed checklist from the relevant guideline appended to 
the submitted manuscript. A collection of reporting guidelines for research in animals is 
available through the Menagerie of Reporting guidelines Involving Animals (MERIDIAN), 
https://meridian.cvm.iastate.edu , which includes REFLECT (O’Connor et al., 2010b; Sargeant et 
al., 2010) and Strengthening the Reporting of Observational Studies in Epidemiology – 
Veterinary Extension (STROBE-Vet) (O’Connor et al., 2016; Sargeant et al., 2016). Both these 
guidelines were developed using published methodological frameworks (REFLECT, O’Connor 
et al., 2010; STROBE-Vet, Sargeant et al., 2016), which were based on published strategies for 
developing health research reporting guidelines (Moher et al., 2010).  In particular, the 
REFLECT guideline was developed by consensus of a group of experts in livestock species, 
considering research with animal health, production, or food-safety outcomes  (O’Connor et al., 
2010e).  Both REFLECT and STROBE-Vet have been endorsed and published by several 
leading journals in food science and veterinary medicine (for REFLECT: Journal of Food 
Protection (O’Connor et al., 2010d; Sargeant et al., 2010b), Journal of Swine Health and 
Production (O’Connor et al., 2010e), Journal of Veterinary Internal Medicine (O’Connor et al., 
2010c), Preventative Veterinary Medicine (O’Connor et al., 2010a), Zoonoses and Public Health 
(O’Connor et al., 2010b; Sargeant et al., 2010a), and is now endorsed by Journal of Dairy 
Science. In addition, guidelines specific to the conduct of systematic reviews (PRISMA, Moher 
et al., 2009), laboratory animal experiments (ARRIVE, Kilkenny et al., 2010), and diagnostic 
accuracy studies (STARD, Kostoulas et al., 2017) are also available.  As well, suggested 
guidelines for particular subject areas have been published in the Journal of Dairy Science (e.g. 
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for studies with calves (Kertz and Chester-Jones, 2004) and in reproduction (Lean et al., 2016)), 
but these do not preclude the need to report general study characteristics for the relevant type of 
study. The MERIDIAN site also offers a Reporting Interface for Guidelines on Research 
(RIGOR)  https://aflex.vrac.iastate.edu/checklist/?t=Reflect , where manuscripts may be 
uploaded to facilitate checklist completion and exported as a portable document format (PDF).  
While there is some evidence that reporting has improved since the publication of 
reporting guidelines for human and animal trials, there is still much room for advancement, as 
many key features remain under-reported (Plint et al., 2006; Totton et al., 2018).  Researchers 
may be unaware that reporting guidelines exist.  For example, a survey of editors of veterinary 
journals showed only one-third had instructions for authors which referred to reporting 
guidelines (Grindlay et al., 2014). Employing reporting guidelines allows for a standardized 
examination of the methodologic soundness of submitted manuscripts, furthering the high 
standards needed to assure journal quality. The role of journals extending beyond being gate-
keepers to driving methodologic change has been well argued (Erb, 2010; More, 2010), and it 
behooves progressive journals to be self-critical and to advance standards. In order to further the 
quality of reporting in the Journal of Dairy Science, it would be beneficial to understand the 
current status of reporting in the Journal, to identify areas of weakness and provide a benchmark 
for future examination. As controlled experiments (i.e. trials) constitute a large proportion of 
published work in the Journal of Dairy Science, we focused our assessment on these.  
 
Objectives 
The objective of this cross-sectional observational study was to describe completeness of 
reporting in a sample of animal trials published in the Journal of Dairy Science in 2017, using 18 
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objective items of the REFLECT statement checklist (O’Connor et al., 2010; Sargeant et al., 
2010).  
 
MATERIALS AND METHODS 
 
As this work was a cross-sectional study, it is reported using the relevant STROBE-vet 
headings for observational studies (O’Connor et al., 2016; Sargeant et al., 2016). The original 
study protocol for this work is available through the University of Guelph Atrium ( 
https://atrium.lib.uoguelph.ca/xmlui/handle/10214/13095 ).  
 
Definitions 
 In this paper, we consider the term ‘trial’ to be synonymous with ‘experiment’ or ‘study’, 
in which the researcher controls the allocation of animals (or groups of animals) to an 
experimental treatment, also known as an ‘intervention’.  Experimental interventions may 
include, but are not limited to, diets, dietary supplements, drug treatments, vaccinations, 
reproductive protocols, housing or management practices, or surgical interventions.  These 
interventions, as well as analyses, may be at different levels, such as udder quarter, cow, pen, or 
farm. 
 
Eligibility criteria 
Publications in the calendar year of 2017 in the Journal of Dairy Science were searched, 
using criteria designed to maximize the likelihood of identifying relevant studies. Interventions 
(i.e. treatments) may be (but are not limited to) diet compositions or supplements, 
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pharmacological products, housing strategies, management practices, or surgical procedures. A 
relevant comparator group also had to be present, and may be an untreated control group, a 
placebo, or an alternative intervention.   
 
Literature search and initial screening 
The search was conducted on May 17, 2018 in MEDLINE via OVID (University of 
Guelph license) with the following string: (AB=(experiment OR study OR studies OR trial OR 
challenge) AND JN=(Journal of Dairy Science) AND limit to YR=“2017”). Search results were 
exported into DistillerSR (Evidence Partners Inc., Ottawa, Ontario, Canada).  All title and 
abstracts were independently screened by two reviewers (KJC and CBW) for relevance using the 
following criteria.   
1.  Does the title or abstract describe a primary study involving animals or groups of                    
animals as the experimental unit? (No, reject; Yes, proceed; Unclear, acquire full text and 
re-screen)  
2.  Does the title or abstract describe an intervention study with at least one comparator 
group? (No, reject; Yes, include; Unclear, acquire full text and re-screen)  
Only those papers reporting intervention studies (i.e. designed experiments) were 
considered relevant, i.e. review articles, observational studies, or previously published data were 
not relevant. The experimental unit had to be a live animal or groups of animals; studies on 
animal products or in vitro studies were not relevant.  
 
Sampling method and reporting assessment 
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Two post-hoc modifications from the original protocol were made: to limit assessment to 
a sample of relevant studies, and to limit the assessment to the prevalence of reporting of 
REFLECT items and not to assess risk of bias using the Cochrane tool (Higgins et al., 2016).  
These change to limit the scope of the study were made to aid in clarity of communication of the 
results. To determine the number of papers to assess, we calculated sample size for estimation of 
a proportion (Dohoo et al. 2010) was based on an estimated prevalence of 40 % of included 
papers reporting a sample size justification (based on results of Totton et al., 2018) with an 
acceptable error (precision) of 10 %, resulting in a minimum of 105 papers. 
Of papers included after initial screening, the first 20 were used to pre-test the reporting 
assessment form among all reviewers (KJC, CBW, DLR, JMS), where any incongruence in 
answers to screening questions were discussed to ensure thorough and complete understanding of 
the questions. An additional 100 papers were selected using a random number generator to select 
the first paper (1 to 3), after which every third paper was included until 100 papers were 
obtained, involving more than one pass of the un-included papers.  After pre-testing in triplicate, 
reporting assessment was done independently by two authors (KJC, CBW, DLR, or JMS), with 
disagreements resolved by consensus. If reviewers were authors on included studies, an 
alternative reviewer was assigned.   
Extracted descriptive characteristics of included trials consisted of: first author affiliation 
(department, institution, country), trial location (country), population, farm type, and study 
design (type of experiment: challenge or field trial; participant paths: cross-over design 
(including Latin Square) or parallel group). Parallel (between-subjects) trials have study units 
assigned to a single treatment, while in crossover (within-subjects) trials, animals act as their 
own controls and receive treatments in a specific order (Lund et al., 1994). Field trials are 
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defined as research conducted in a clinical or field setting (including research herds) which 
involve investigator control of study unit selection and treatment allocation, but with natural 
development of the disease or outcome, whereas challenge trials involve purposive exposure to a 
pathogen or surrogate (which may occur ahead of (therapeutic challenge), or after (preventative 
challenge), the intervention).  For example, intramammary inoculation with E. coli, manipulation 
of ruminal pH to simulate an acidosis event, or administration of a lipopolysaccharide, constitute 
experimental challenges. 
For papers reporting multiple experiments, a separate reporting assessment was done for 
each trial reported in the manuscript. The REFLECT checklist is included as supplementary 
Table 1. Reporting assessment was based on the survey questions designed by Totton et al. 
(2018), where items 1 and 3 to 19 (of 22) in REFLECT were rephrased into questions (Table 2). 
Items 2, 20, 21, and 22 (appropriate scientific background given; appropriate interpretation of 
results accounting for hypotheses, sources of bias, and multiplicity of analyses or outcomes; 
external validity; and general interpretation of results), were not included because these items 
involve judgement to determine whether items have been comprehensively discussed.  
Conversely, the included items only require a determination of whether information on the 
design element is present or absent.  For example, no judgement is required to determine whether 
or not a study described the method of allocation sequence generation (item 8), in contrast to 
assessing whether the authors included an appropriate interpretation of the generalizability of the 
results (excluded item 21).  
In addition to the subdivision of items 3, 5, 10, and 11 by Totton et al. (2018), we also 
subdivided items 6, 7, and 8.  Items 3, 5, 10, and 11 were split by the previous authors as they 
concerned more than one piece of information, while items 6 and 7 were subdivided as it was 
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expected that few studies would have reported sample size justification, and item 8 was modified 
to include a question on random allocation reported elsewhere in the manuscript, and to capture 
those reporting a method of study unit allocation which was not random (e.g. systematic 
assignment). Two questions pertained to cross-over studies’ reporting of washout periods, which 
was not specifically included in REFLECT. The denominator for all items was the total number 
of included trials, with the exception of washout period questions only pertained to cross-over 
trials, and subdivisions of item 8 only pertaining to studies reporting random allocation of study 
units.    
 
Statistical analysis and presentation of results 
After consensus was achieved for all included studies, results were exported from 
DistillerSR into STATA/SE 15.0 (StataCorp, College Station, TX) where descriptive statistics 
were tabulated for all fields. Study characteristics and the comprehensive reporting assessment 
are reported as tables. 
 
RESULTS AND DISCUSSION 
 
     Because this study was limited to describing completeness of reporting of aspects of trial 
design, implementation, and analysis, we consciously limit our speculation on reasons as to why 
items were not reported.  In addition, it is important to note that completeness of reporting does 
not assess the risk of bias in the trials examined, although completeness of reporting is a 
prerequisite for assessment of risk of bias by the reader or reviewer. Specific design elements 
such as randomization or blinding may have greater or lesser importance depending on the nature 
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of the experiment, but completely reporting what was done is fundamental to all scientific 
papers. Comprehensive reporting is a pre-requisite in order for the reader to be able to undertake 
a subject-specific interpretation of the specific design elements. 
 
Study population and descriptive characteristics 
The inclusion of studies is summarized in Figure 1. Of the 595 articles found in the 
literature search, 230 (39 %) were included after relevance screening, and every third article was 
included until 120 papers sampled for study characteristics and assessed for reporting criteria, 
which reported 137 unique trials. Eleven papers contained multiple trials. Included studies are 
available as supplemental file S1. 
The study characteristics are outlined in Table 1.  Dairy cattle were the population in the 
majority of the sampled studies, although studies involving dairy calves or heifers, dairy goats, 
and dairy sheep were also represented. Nearly one-quarter of studies did not report the trial 
setting; of those which did report, research or university farms were most common. First author 
affiliations included 29 department types (e.g. dairy science, animal biology), from 66 
institutions (including government, academia, and private industry), and 24 countries from 5 
continents. Field trials were most common (131/137), which may be completed in commercial or 
research herds, and involve investigator control of study unit selection and intervention 
allocation, but not exposure to disease or outcome. Challenge studies accounted for the 
remainder (6/137), where the investigator controls study unit selection and intervention 
allocation, and there is purposive exposure to disease as described above. One-third (42/137) of 
the experiments used a cross-over design while two-thirds (95/137) had parallel groups.  
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 Reporting assessment 
The prevalence of reporting of REFLECT items is outlined in Table 2.  Further 
discussion on assessment of items and explanation of the item are outlined below; a brief 
explanation of the importance of each item is based on the REFLECT Explanation and 
Elaboration document (Sargeant et al., 2010) which provides a more detailed explanation and 
examples for each item.  
Title/abstract (1).  Random allocation of study units was reported in 87 of the 137 
included trials; an additional 17 studies reported this information elsewhere in the text.  It is 
recommended that this study design information is included in the title or abstract to facilitate 
identification of the study in literature searches, for example when conducting systematic 
reviews. For this reason, REFLECT also recommends the use of the terms ‘challenge trial 
(/study, /model)’, and ‘field trial’ or ‘clinical trial’ in the title or abstract. The proportion of 
studies that reported random allocation of study units was substantially greater than a sample of 
livestock trials examined in 2008, in which only 26 % reported this (Sargeant et al., 2009a).  
However, it is unclear how many JDS manuscripts were included in that sample. Totton et al. 
(2018) similarly found that this item showed significant improvement (OR=1.97, 95% CI=1.23-
3.16) since the publication of REFLECT, where the post-2010 sample had 17 of 28 studies 
reporting this item.  
It should be noted that while ‘study units’ may not be clearly or consistently, or always 
even correctly defined in the dairy science literature (Bello et al., 2016), this item only captures 
whether or not study units were reported, not whether the study unit was defined or analysed 
appropriately.  REFLECT includes the synonyms of ‘unit of concern’ or ‘experimental unit’; for 
example, a study unit may be a mammary quarter, animal, pen, or farm (Sargeant et al, 2010). 
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Methods – participants (3). Understanding potentially important differences between the trial 
and the target population is important to assessing external validity; while settings were well 
reported (126/137), eligibility criteria were less commonly reported at both the animal (75/137) 
and farm (6/137) levels.  Conducting a trial in a university or research herd affords a degree of 
control over some variables which may improve internal validity, with the trade-off that the 
results may be less easily generalized to commercial circumstances. In some cases, use of a 
research facility may be necessary to determine the outcome, for instance this requires rumen 
fistulation or sacrifice for post-mortem sampling. Reporting is most complete if it explicitly 
states why the trial was conducted in a given setting. As two-thirds of our sample trials were 
done in university herds, we speculate that authors may not have seen the need to specify why 
the trial was conducted in their own institutional herd. There is evidence that studies failing to 
report inclusion and exclusion criteria are more likely to report a positive treatment effect in both 
livestock (Sargeant et al., 2009a) and companion animal trials (Sargeant et al., 2010).  
Methods – interventions (4).  Both details of interventions and the level (individual 
animal vs. pen, group, or farm) at which they were administered were commonly reported in our 
sample (134/137).  The interventions in studies in our sample was almost always given at the 
individual animal level; cluster (group) allocation was uncommon.  Details on intervention 
administration is mentioned in the Journal’s Instructions for Authors document, which may be 
why a greater degree of compliance with this item was seen.  This was similar to a review of 
reporting of trials on bovine respiratory disease (Totton et al., 2018), in which 93 % of the 
studies published after 2010 reported this item. Lack of compliance with this item has also been 
shown to be associated with reporting positive treatment effects (Sargeant et al., 2009a); it is 
encouraging that this item appears to be well reported in our sample. 
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 Methods - objectives, hypotheses (5). All intervention studies should clearly state an objective 
and the hypotheses to be tested; while 127/137 explicitly reported study objectives, only 97/137 
stated a hypothesis in terms of the null hypothesis. Understanding if the trial is designed to test 
superiority, non-inferiority, or equivalence will allow the reader to better interpret the results, 
and gather whether appropriate sample size calculations and statistical analyses were done. 
Similarly, while objectives were reported in 96 % of field trials examining antimicrobial 
treatments for bovine respiratory disease, hypotheses were stated in only 32 % (Totton et al., 
2018).  The Instructions for Authors in the Journal mention the need for an explicitly stated 
hypothesis, which may contribute to generally good reporting.   
Methods - outcomes (6). Reporting of the primary and secondary outcomes was rarely 
done (13/137), which correlates with the absence of information about sample size rationale in 
the included studies (item 7). In a similar study of pre-harvest food safety intervention trials, the 
primary outcome was only defined in 10 % of abstracts examined in a 2009 study (Snedeker et 
al., 2012), and none in a 2008 evaluation of full papers (Sargeant et al., 2009b). The primary 
outcome can be determined several ways. Most commonly it is the outcome on which the sample 
size calculation was based or it may be explicitly stated in the trial protocol, while secondary 
outcomes are ones for which no explicit sample size was calculated. If a sample size for more 
than one outcome was calculated, the outcome with the largest required sample size required is 
referred to as primary. This allows the reader to judge whether the trial was appropriately 
powered to detect a meaningful difference. 
The level at which outcomes were measured, and details of the methods used to enhance 
the quality of measurements was generally reported (127/137). The latter may include standards 
of laboratory testing, duplicated sampling, and training of outcome assessors.   
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Methods – sample size (7). This fundamental aspect of study design was infrequently 
reported, with 22/137 reporting a sample size justification, of which 16 of the 22 included a 
sample size calculation as justification.  It should be noted that nearly all trials included in our 
sample had multiple outcomes; it is important to inform the reader as to which outcomes were 
considered in the calculation, and if any non-independence was accounted for. Sample size 
calculations allow a consideration of the appropriate power and sampling error for experimental 
studies, and and are therefore considered an important component of methodological rigour in 
trial design (Latif et al., 2016). It is inconsistent with the principles of use of animals for research 
to conduct an experimental study involving animals that is either under- or over-powered. When 
reported, sample size calculations also allow the reader to know which hypothesis was primary.  
Sample size should consider the nature of the outcome data (e.g. continuous, dichotomous, time-
to-event), the variability between study units in the outcome, the expected magnitude of the 
effect of treatment, and the desired level of confidence in the result and power of the study 
(Dohoo, 2004). 
However, some studies do not use formal sample size calculation; for example, in our 
sample, 6 papers reported that sample size was determined based on use of animals enrolled in a 
concurrent or previous trial. Regardless, it is still important to report how the sample size was 
determined for transparency and to aid the reader in understanding power and the potential role 
of chance. This finding also illustrates how comprehensive reporting assessment differs from 
bias assessment. These six studies did report the rationale for the sample size and that is what 
REFLECT recommends. Our findings were similar to that of Totton et al. (2018), where 
approximately one-third reported how the sample size was determined.  Totton et al. (2018) did 
not show a change over time for this item, although earlier work (albeit in a different field, small 
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animal clinical trials) found no studies in their sample reporting how sample size was determined 
(Lund et al., 1998). An evaluation of trials examining the efficacy of prostaglandin F2α for 
treatment of bovine endometritis also found that none included a sample size calculation 
(Haimerl et al., 2012).  
The Journal requires that authors state explicitly that IACUC (or equivalent animal ethics 
or animal use) approval was obtained prior to commencement of the study.  In almost all cases, 
ethical approval would require the identification of a primary outcome and hypothesis, around 
which the sample size was calculated.  Therefore, we suspect that the lack of compliance for this 
item stems from a lack of reporting, as opposed to a lack of inclusion of this aspect of study 
design.  
Methods – washout period (N/A). This item is not part of the REFLECT statement, but 
was considered by the authors to be an important reporting aspect of cross-over trials; knowledge 
of the washout period length and justification is necessary to determine if the population was 
equivalent before the start of each block. Washout periods were reported in 21 of 45 cross-over 
studies, but only one trial reported a justification for washout period length.   
Methods – randomization (8, 9, 10). Randomization is used to minimize baseline 
differences at the time of the intervention (de Boer et al., 2015). The REFLECT statement 
recommends that authors describe the method used to generate the random sequence, which pre-
supposes that all studies are randomized.  Random allocation of study units was reported in 104 
studies, but only 7 of these reported the method used to generate the sequence. This is similar to 
a study of veterinary clinical trials (Lund et al., 1998), in which only 12 % reported on the 
method. This item about method of sequence generation is designed to ensure that authors are 
not incorrectly describing a study as random when in fact alternation methods or haphazard 
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methods of allocation were employed. Many of the assumptions for validity of statistical 
methods are reliant on the concept of exchangeable groups, which is established by 
randomization, and so it is critical that authors use the word random only when the approach to 
allocation actually is random. It is possible that random allocation was indeed used in more than 
7 trials, but without explicit reporting this not possible to ascertain. Interestingly, this particular 
item was examined in a survey of controlled trials published in five veterinary journals, where an 
attempt to contact the authors of the trials was made to see if further details on randomization 
could be obtained; two-thirds of contacted authors were unable to provide further information 
(Di Girolamo et al., 2017).  This highlights the need for complete reporting in the original 
publication. 
Restrictions or blocking variables were reported in 51 of 104 studies, where variables 
were stratified and allocation occurred within the strata (e.g. sex, parity, weight category, etc.) to 
minimize differences in covariates between groups. 
The method used to implement the random allocation sequence, specifying if it was 
concealed until interventions were assigned, was reported in 3 of 104 randomized trials. Only 
one trial reported who generated the allocation sequence and who enrolled study units. Bias may 
be introduced if the sequence of allocation is known by the person enrolling study units, 
especially if units have unequal value (for example, a farm manager enrolling dairy cattle might 
have conscious or unconscious preferences about their animals). This differs from blinding in 
that knowledge of the intervention group sequence (although blinded) may influence enrollment.   
Methods – blinding (11). Whether or not blinding was employed was infrequently 
reported; 17/137 studies reported if blinding was implemented for any stage of the trial (those 
administering the intervention, caregivers, outcome assessors, or those analysing data). Blinding 
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is important for internal validity, because a lack of blinding has potential to influence, 
consciously or unconsciously, measures post-enrollment such as animal management and 
assessment of outcomes.  If blinding is not possible at one or more level(s), this should be 
reported.  It is important to state who is and is not blind to treatment groups.  In some situations, 
blinding of outcome assessors may be less important, if the outcome can only be measured one 
way (such as mortality), or if the outcome is very objective.  This could be interpreted differently 
than blinding of caregivers, where differential management of treatment groups may have 
substantial influence (Ribble, 1990). Our results differ from similar work examining reporting in 
field trials of antimicrobial therapy for bovine respiratory disease, where although blinding was 
infrequently reported for those administering interventions (25 %), caregivers (7 %), or data 
analysis (0 %), blinding was commonly reported for outcome assessors (86 %) (Totton et al., 
2018). 
Methods – statistical analysis (12). A clear explanation of the statistical analyses 
performed, including methods used to account for the organizational structure of the data, is 
necessary to assess internal validity of a trial. This item was almost universally reported 
(135/137), although it should be noted that this does not imply that all analyses were appropriate, 
only that the approach taken was reported and any accounting for non-independence was 
described. Some details on reporting of statistical analysis are included in the Journal’s 
Instructions for Authors, which may be why a greater degree of compliance with reporting of this 
item was seen.   
Results – study flow (13). The number of study units enrolled, receiving the intervention, 
completing the trial, and analysed should be reported.  If deviation from the trial protocol or loss 
to follow up is relatively uncommon or simple (for short-term studies), this can be described in 
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the text, whereas a flow diagram is recommended to show the organizational structure for 
longer-term studies or those with complex design or multiple organizational levels (e.g. animals 
in pens in herds).  The study flow was reported in half (68/137) of included studies, the majority 
of which were short-term interventions with data available in the text. 
Results – recruitment (14). The dates when the trial took place were infrequently 
reported (51/137).  Field conditions may be seasonal, and reporting when the trial occurred is 
important for the reader to place the trial population and results in an appropriate context. 
Results – baseline data (15). Demographic and clinical characteristics of the trial 
population by intervention group were reported in 37/137 studies. Clinical characteristics are 
synonymous with biological measurements, such as rumen pH, somatic cell count, or 
haematological variables, etc., while demographic characteristic include, for example, breed, 
weight, sex, and parity. While randomization aims to generate comparable intervention groups, 
differences may occur due to chance, and the reviewer and reader should be presented with the 
group characteristics. Similar to our findings, only 37 % of studies evaluating pre-harvest food 
safety interventions reported baseline data (Sargeant et al., 2009b).  Many studies did not report 
baseline characteristics by group, instead presenting an overall value and stating a non-
significant test of baseline differences. Statistically testing for baseline differences is not 
recommended for randomized studies (de Boer et al., 2015), because truly random allocation 
means the differences must be due to chance. However, adjustment for baseline differences in 
analyses may be appropriate (Roberts and Torgerson, 1999). Failure to report baseline data for 
treatment groups has been associated with a greater proportion of positive treatment effects 
(Sargeant et al., 2010), highlighting the importance of reporting this item in order for the reader 
to appropriately interpret the study results. 
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Results – number analysed (16). The number of study units analysed in each group was 
reported for 78/137 studies. It is important to note that the recommendation is to report the study 
units in the denominator; it is up to the authors, reviewers, and readers to assess which unit is 
appropriate for the specific outcome (e.g. it may be the unit of allocation, the unit of observation, 
or the effective sample size). Stating such allows the reader to determine if the unit is 
appropriate, and to assess loss to follow up and protocol deviations.  A similar prevalence (64 %) 
of reporting of this item was found in an assessment of trials examining antimicrobial therapies 
for bovine respiratory disease (Totton et al., 2018). 
Results – outcomes and estimation (17). Effect sizes (i.e. the magnitude of effects of 
treatment) were commonly reported, but less so for summary level data, with 89/137 reporting 
both.  In many cases it was not clear if the effect was unadjusted or adjusted for specified co-
variates, but the precision of the estimate (e.g. standard error or 95 % confidence intervals) was 
generally well reported (131/137). 
Results – ancillary analyses (18). Analyses were almost never (1/137) reported to be pre-
specified or exploratory.  Multiplicity of analyses increases the risk of a type I error, which may 
be additionally influenced by multiplicity of outcomes. Failure to report measurement of all 
outcomes described has been associated with a higher probability of reporting positive treatment 
effects (Sargeant et al., 2009a). It is not uncommon that additional (i.e., not pre-planned) 
analyses are done, perhaps based on initial results, but it is important to state this in order to 
appropriately interpret analyses as pre-planned or exploratory.  For example, unplanned contrasts 
have a different interpretation than those pre-planned and for which the sample was derived. This 
said, determining if analyses were pre-specified generally requires a priori documentation, such 
as a time-stamped document published ahead of the experiment to state the planned experimental 
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protocol.  Recommendations for protocols for human intervention trials, such as the Standard 
Protocol Items: Recommendations for Intervention Trials (SPIRIT) checklist have been 
published for guidance (Chan et al., 2012).  In human medicine, trial protocols are increasingly 
required to be registered and publicly available (e.g. ClinicalTrials.gov) at the start of a study, 
and may be published in peer-reviewed journals. University repositories may be available to 
some research groups to publish time-stamped PDF documents, or we suggest that a time-
stamped PDF protocol could be included as supplementary material when the experiment is 
published. This would allow for a clear delineation of outcome(s) and analyses were pre-planned 
to test a specific hypothesis, and prevent hypothesizing after the results are known, which 
increases the risk of a type I error, promotes inappropriate statistical practices, and potentially 
loses information about the original hypothesis (Kerr, 1998). 
Results – adverse events (19). Few (10/137) studies reported adverse events. It is 
possible that this is because such events usually did not occur, however, without a statement as to 
whether such events occurred, it is not possible to be sure.  While adverse events may not 
necessarily be the result of the intervention, they should be reported.  If no adverse events were 
experienced, this should also be reported for transparency and because knowledge of adverse 
events is an important part of decision-making. 
  
CONCLUSIONS 
 
This work provides a benchmark of the completeness of reporting of key items for 
intervention trials published in the Journal of Dairy Science in 2017. Similar to other findings in 
both animal and human trials, while some items were well reported, there is room for 
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improvement in many areas.  It is encouraging to see that several items appear to be very well-
reported, such as details of experimental treatment administration and the approach to statistical 
analysis.  It is interesting to note these items are clearly outlined in the Journal’s Instructions to 
Authors, suggesting that further endorsement of reporting of design elements can result in 
improved reporting in the Journal. 
We emphasize that adherence to reporting guidelines is not a measure of study quality, 
but serves to provide the reader or reviewer with the appropriate information in order to assess 
the work.  Without transparent reporting, the reader or reviewer is unable to accurately assess 
areas of weakness or potential bias.  The endorsement of reporting guidelines by the Journal 
should serve to encourage authors to consult such guidelines before embarking on a trial (to 
ensure appropriate considerations are taken in study design) and to submit the appropriate 
completed checklist with manuscript submission. Reviewers for the Journal should require 
authors to report fully and explicitly, which will expedite the review process and allow for 
identification of methodological flaws and appropriate interpretation of published studies. 
Adherence to reporting guidelines will serve to advance the Journal’s high standards and 
increase the value of the research published within. 
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Figure 1. Flow of published articles through the initial database search, relevance screening, and 
sampling for extraction of study characteristics and reporting assessment of intervention trials 
published in the Journal of Dairy Science in 2017 for adherence to REFLECT items 1, and 3 to 
19 (Sargeant et al., 2010). 
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Table 1. Characteristics of 137 intervention trials in animals from 120 selected papers published 
in 2017 in the Journal of Dairy Science. 
Descriptive item Proportion of studies 
in the sample 
 
Study population1 
 
Dairy cows 72 % 
 
Dairy calves/heifers 23 % 
 
Dairy goats 6 % 
 
Dairy sheep 
 
1 % 
 
Farm type Commercial 13 % 
 
University/research 63 % 
 
Not reported 
 
24 %  
 
Study design: Experiment 
type 
 
 
 
Experimental challenge2 4 % 
 
Field trial3 
 
96 % 
 
Study design: Participant 
paths 
Cross-over 33 % 
 
Parallel 67 % 
1 Categories are not mutually exclusive 
2 Challenge studies involve investigator control of study unit selection, intervention allocation, and purposive 
exposure to disease or outcome 
3 Field trials may be conducted in a clinical or field setting (including research herds) and involve investigator 
control of study unit selection and intervention allocation, but with natural exposure to disease or outcome 
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Table 2. Prevalence of reporting characteristics from 137 intervention trials in animals in 120 
papers published in 2017 in the Journal of Dairy Science. Questions are taken from Totton et al. 
(2018), with additional subdivision of REFLECT1 item 6, 7, and 8.  An additional question was 
added to item 8 to capture studies reporting random allocation outside of title or abstract.  An 
item specific to cross-over studies on reporting of washout periods was included (text in italics) 
but is not part of the REFLECT checklist.  
REFLECT 
item 
number 
Question Prevalence  
(affirmative answer 
to the question; the 
information was 
reported) 
1. In the Title and/or Abstract, did the investigators report that the study 
units were randomly allocated to the interventions? 
87 / 137 
(64 %) 
 
3. In the Methods, did the investigators report eligibility criteria for the 
farm/owner/manager? 
6 / 137    
(4 %) 
 
 
In the Methods, did the investigators report study unit (animal or 
animal group) eligibility? 
75 / 137  
(55 %) 
 
 
In the Methods, was the setting where the data were collected 
described? 
 126 / 137 
(92 %) 
 
4. In the Methods, did the investigators give precise details of the 
interventions intended for each group, the level at which the 
intervention was allocated, and how and when interventions were 
actually administered?  
 
134 / 137 
(98 %) 
 
 
5. Did the investigators report the specific objectives of the study? 127 / 137  
(93 %) 
 
Did the investigators report the specific hypotheses of the study? 97 / 137  
(71 %) 
 
6. Did the investigators give clearly defined primary and secondary 
outcome measures?  
13 / 137   
(9 %) 
 
Did the investigators report levels at outcomes were measured, and, 
when applicable, any methods used to enhance the quality of the 
measurements? 
127 / 137  
(93 %) 
 
 
7. Did the investigators provide a justification for sample size? 
 
 
Did the investigators provide a calculation for sample size? 
 
22 / 137  
(16 %) 
 
16 / 137  
(12 %) 
 
Were interim analyses reported?  1 / 137 
 (1 %) 
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Were stopping rules used?  0 / 137 
 (0 %) 
 
N/A Was a washout period reported?ba 21 / 45  
(47 %) 
 
Was an explanation for washout period length providedb 1 / 21   
 (5 %) 
 
8. Did the investigators report using a random allocation sequence at the 
relevant level of the organizational structure? 
104 / 137   
(76 %) 
 
 
Was the method used to generate the random allocation sequence 
reported? 
7 / 104    
(7 %) 
 
Were blocking factors or restrictions reported? 51 / 104   
(49 %) 
 
Was allocation method reported but non-random (e.g. systematic)?   7 / 137  
 (5 %) 
 
9. Did the investigators report the method used to implement the random 
allocation sequence at the relevant level of the organizational 
structure, (e.g. numbered containers), clarifying whether the sequence 
was concealed until interventions were assigned? 
 
3 / 104    
(3 %) 
 
 
 
10. Did the investigators report who generated the allocation sequence? 1 / 137    
(1 %) 
 
Did the investigators report who enrolled study units? 1 / 137 
 (1 %) 
 
Did the investigators report who assigned study units to their groups at 
the relevant level of the organizational structure?  
1 / 137    
(1  %) 
 
 
11. Did the investigators report whether those administering the 
interventions were blinded?  
  8 / 137  
  (6 %) 
 
Did the investigators report whether caregivers were blinded?  9 / 137   
 (7 %) 
 
Did the investigators report whether those assessing all outcomes were 
blinded?  
 11 / 137  
 (8 %) 
 
 
Did the investigators report whether those assessing any outcomes 
were blinded?c  
  17 / 137 
  (12 %) 
 
Did the investigators report whether those analyzing the data were 
blinded? 
  3 / 137   
  (2 %) 
 
Did the investigators report blinding (or the absence of blinding) at 
all? 
 17 / 137  
 (12 %) 
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12. Were statistical methods used to compare groups for all outcome(s), 
and did the investigators clearly state the level of statistical analysis 
and methods used to account for the organizational structure (where 
applicable)? 
  135 / 137 
  (99 %) 
 
 
 
13.  In the Results, did the investigators report the flow of study units 
through each stage for each level of the organization structure of the 
study? 
68 / 137   
(50 %) 
 
 
14. Did the investigators report dates defining the periods of recruitment 
and follow-up? 
51 / 137  
(37 %) 
 
 
15. Did the investigators report the baseline demographic and clinical 
characteristics of each group, explicitly providing information for each 
relevant level of the organizational structure? 
 37 / 137  
 (27 %) 
 
 
16. Did the investigators report the number of study units (denominator) 
in each group included in each analysis and the results in absolute 
numbers when feasible? 
78 / 137   
(57 %) 
 
 
17. Did the investigators report a summary of results for each intervention 
group, accounting for each relevant level of the organizational 
structure, and the estimated effect size and its precision (e.g. 95% 
confidence interval)? 
89 / 137   
(65 %) 
 
 
 
18. Did the investigators address multiplicity by reporting any other 
analyses performed, including subgroup analyses and adjusted 
analyses, indicating those pre-specified and those exploratory? 
1 / 137    
(1 %) 
 
 
19. Did the investigators report all important adverse events or side effects 
in each intervention group?  
 10 / 137   
 (7 %) 
 
a Sargeant et al., 2010 
b Item not included in the REFLECT checklist 
c Includes blinding of any or all outcome assessors 
 
